.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Novartis
Merck
Fuji
Baxter
AstraZeneca
Queensland Health
Harvard Business School
Mallinckrodt
Accenture

Generated: February 22, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: indinavir sulfate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Merck Sharp DohmeCRIXIVANindinavir sulfateCAPSULE;ORAL020685NDAMerck Sharp & Dohme Corp.N0006-0571-43
Merck Sharp DohmeCRIXIVANindinavir sulfateCAPSULE;ORAL020685NDAMerck Sharp & Dohme Corp.N0006-0573-62
Merck Sharp DohmeCRIXIVANindinavir sulfateCAPSULE;ORAL020685NDARebel Distributors CorpE21695-366-18
Merck Sharp DohmeCRIXIVANindinavir sulfateCAPSULE;ORAL020685NDAState of Florida DOH Central PharmacyE53808-0661-1
Merck Sharp DohmeCRIXIVANindinavir sulfateCAPSULE;ORAL020685NDAAvera McKennan HospitalE69189-0574-1
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
US Department of Justice
AstraZeneca
Colorcon
Federal Trade Commission
Boehringer Ingelheim
Accenture
McKinsey
Daiichi Sankyo
Moodys

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot